Clinical trial

ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.

NCT04061798 · Dijklander Ziekenhuis, Other · Terminated

Key facts

NCT number NCT04061798
Title ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.
Official title ACTION-1: ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair, a Randomised Trial.
Acronym ACTION-1
Lead sponsor Dijklander Ziekenhuis, Other
Collaborators ZonMw: The Netherlands Organisation for Health Research and Development Amsterdam UMC, location VUmc Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status Terminated
Phase Phase 4
Study type Interventional
Conditions Abdominal Aortic Aneurysm, Surgery, Arterial Disease
Intervention type Drug
Interventions ACT guided heparinization, 5 000 IU of heparin
Enrollment 294
Start date Mar 2, 2020
Primary completion Apr 13, 2024
Completion Apr 29, 2024
First posted Aug 20, 2019
Last update posted Feb 6, 2025
Countries Germany, Netherlands

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies